140 related articles for article (PubMed ID: 11878807)
1. A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme.
Jin G; Huang X; Black R; Wolfson M; Rauch C; McGregor H; Ellestad G; Cowling R
Anal Biochem; 2002 Mar; 302(2):269-75. PubMed ID: 11878807
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
Neumann U; Kubota H; Frei K; Ganu V; Leppert D
Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
[TBL] [Abstract][Full Text] [Related]
4. New fluorogenic substrates for N-arginine dibasic convertase.
Csuhai E; Juliano MA; Pyrek JS; Harms AC; Juliano L; Hersh LB
Anal Biochem; 1999 Apr; 269(1):149-54. PubMed ID: 10094786
[TBL] [Abstract][Full Text] [Related]
5. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.
Johnson GD; Ahn K
Anal Biochem; 2000 Nov; 286(1):112-8. PubMed ID: 11038281
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
Pennington MW; Thornberry NA
Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
[TBL] [Abstract][Full Text] [Related]
7. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
8. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate.
Welch AR; Holman CM; Browner MF; Gehring MR; Kan CC; Van Wart HE
Arch Biochem Biophys; 1995 Dec; 324(1):59-64. PubMed ID: 7503560
[TBL] [Abstract][Full Text] [Related]
9. ADAM33 enzyme properties and substrate specificity.
Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
[TBL] [Abstract][Full Text] [Related]
10. A phosphotyrosine-containing quenched fluorogenic peptide as a novel substrate for protein tyrosine phosphatases.
Nishikata M; Suzuki K; Yoshimura Y; Deyama Y; Matsumoto A
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):385-91. PubMed ID: 10510304
[TBL] [Abstract][Full Text] [Related]
11. Development of an internally quenched fluorescent substrate and a continuous fluorimetric assay for Streptococcus pneumoniae signal peptidase I.
Peng SB; Zheng F; Angleton EL; Smiley D; Carpenter J; Scott JE
Anal Biochem; 2001 Jun; 293(1):88-95. PubMed ID: 11373083
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
13. Development of in vitro peptide substrates for human rhinovirus-14 2A protease.
Wang QM; Johnson RB; Sommergruber W; Shepherd TA
Arch Biochem Biophys; 1998 Aug; 356(1):12-8. PubMed ID: 9681985
[TBL] [Abstract][Full Text] [Related]
14. A fluorescent peptide substrate for the surface metalloprotease of Leishmania.
Bouvier J; Schneider P; Malcolm B
Exp Parasitol; 1993 Mar; 76(2):146-55. PubMed ID: 8454023
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of pro-tumor necrosis factor alpha by ADAM metallopeptidase domain 17: a fluorescence-based protease assay cleaves its natural protein substrate.
Zhang C; Zheng L; Nurnberg J; Vacari BM; Zhou J; Wang Y
Anal Biochem; 2014 Jan; 445():14-9. PubMed ID: 24096196
[TBL] [Abstract][Full Text] [Related]
16. Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Sawa M; Kurokawa K; Inoue Y; Kondo H; Yoshino K
Bioorg Med Chem Lett; 2003 Jun; 13(12):2021-4. PubMed ID: 12781187
[TBL] [Abstract][Full Text] [Related]
17. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate.
Hurtado O; Lizasoain I; Fernández-Tomé P; Alvarez-Barrientos A; Leza JC; Lorenzo P; Moro MA
J Cereb Blood Flow Metab; 2002 May; 22(5):576-85. PubMed ID: 11973430
[TBL] [Abstract][Full Text] [Related]
18. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of inhibitive effectiveness of the tumour necrosis factor-α converting enzyme selective inhibitors by HPLC.
Zhao Y; Yu J; Gu J; Huang W
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):181-7. PubMed ID: 21406033
[TBL] [Abstract][Full Text] [Related]
20. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ
J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
